Ovarian Cancer Stem Cells with High ROR1 Expression Serve as a New Prophylactic Vaccine for Ovarian Cancer

Tumor vaccines offer a number of advantages for cancer treatment. In the study, the vaccination with cancer stem cells (CSCs) with high expression of the type I receptor tyrosine kinase-like orphan receptor (ROR1) was evaluated in a murine model for the vaccine's immunogenicity and protective e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunol Res
Main Authors: Wu, Di, Yu, Xiaoyu, Wang, Jing, Hui, Xu, Zhang, Yunxia, Cai, Yunlang, Ren, Mulan, Guo, Mei, Zhao, Fengshu, Dou, Jun
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6441513/
https://ncbi.nlm.nih.gov/pubmed/31008116
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/9394615
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados